Literature DB >> 19147836

Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Dai Miyazaki1, Takao Nakamura, Masaharu Ohbayashi, Chuan Hui Kuo, Naoki Komatsu, Keiko Yakura, Takeshi Tominaga, Yoshitsugu Inoue, Hidemitsu Higashi, Meguru Murata, Shuzo Takeda, Atsuki Fukushima, Fu-Tong Liu, Marc E Rothenberg, Santa Jeremy Ono.   

Abstract

The immune response is regulated, in part, by effector cells whose activation requires multiple signals. For example, T cells require signals emanating from the T cell antigen receptor and co-stimulatory molecules for full activation. Here, we present evidence indicating that IgE-mediated hypersensitivity reactions in vivo also require cognate signals to activate mast cells. Immediate hypersensitivity reactions in the conjunctiva are ablated in mice deficient in eotaxin-1, despite normal numbers of tissue mast cells and levels of IgE. To further define the co-stimulatory signals mediated by chemokine receptor 3 (CCR3), an eotaxin-1 receptor, effects of CCR3 blockade were tested with an allergic conjunctivitis model and in ex vivo isolated connective tissue-type mast cells. Our results show that CCR3 blockade significantly suppresses allergen-mediated hypersensitivity reactions as well as IgE-mediated mast cell degranulation. We propose that a co-stimulatory axis by CCR3, mainly stimulated by eotaxin-1, is pivotal in mast cell-mediated hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147836      PMCID: PMC2638875          DOI: 10.1093/intimm/dxn137

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  37 in total

Review 1.  The role of chemokine receptors in primary, effector, and memory immune responses.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 3.  Molecular genetics of allergic diseases.

Authors:  S J Ono
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

4.  Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences.

Authors:  D Miyazaki; G Liu; L Clark; S J Ono
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-11       Impact factor: 4.799

Review 5.  Mast-cell responses in the development of asthma.

Authors:  C O Bingham; K F Austen
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

6.  A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy.

Authors:  S P Hogan; A Mishra; E B Brandt; P S Foster; M E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model.

Authors:  T Kobayashi; T Miura; T Haba; M Sato; I Serizawa; H Nagai; K Ishizaka
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements.

Authors:  N Zimmermann; B L Daugherty; J L Kavanaugh; F Y El-Awar; E A Moulton; M E Rothenberg
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

9.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation.

Authors:  Weilie Ma; Paul J Bryce; Alison A Humbles; Dhafer Laouini; Ali Yalcindag; Harri Alenius; Daniel S Friend; Hans C Oettgen; Craig Gerard; Raif S Geha
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

10.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness.

Authors:  Alison A Humbles; Bao Lu; Daniel S Friend; Shoji Okinaga; Jose Lora; Amal Al-Garawi; Thomas R Martin; Norma P Gerard; Craig Gerard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

View more
  7 in total

1.  Development of a T(H)17 immune response during the induction of murine syngeneic graft-versus-host disease.

Authors:  J Anthony Brandon; C Darrell Jennings; Alan M Kaplan; J Scott Bryson
Journal:  Cytokine       Date:  2010-09-15       Impact factor: 3.861

2.  The function of CCR3 on mouse bone marrow-derived mast cells in vitro.

Authors:  Sarah J Collington; John Westwick; Timothy J Williams; Charlotte L Weller
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

3.  Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis.

Authors:  Chuan-Hui Kuo; Andrea M Collins; Douglas R Boettner; YanFen Yang; Santa J Ono
Journal:  J Immunol       Date:  2016-12-12       Impact factor: 5.422

4.  Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.

Authors:  Santa J Ono; Keith Lane
Journal:  Drug Des Devel Ther       Date:  2011-02-08       Impact factor: 4.162

Review 5.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

6.  CCR3 Monoclonal Antibody Inhibits Eosinophilic Inflammation and Mucosal Injury in a Mouse Model of Eosinophilic Gastroenteritis.

Authors:  Dae Jin Song; Mun Hee Shim; Nahyun Lee; Young Yoo; Ji Tae Choung
Journal:  Allergy Asthma Immunol Res       Date:  2017-07       Impact factor: 5.764

7.  Total IgE and eotaxin (CCL11) contents in tears of patients suffering from seasonal allergic conjunctivitis.

Authors:  Simone Eperon; Marouen Berguiga; Pierluigi Ballabeni; Catherine Guex-Crosier; Yan Guex-Crosier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-12       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.